New hope for Tough-to-Treat lung cancer: targeted drug shows promise
NCT ID NCT04644237
Summary
This study tested a drug called trastuzumab deruxtecan for people with advanced non-small cell lung cancer that has a specific genetic change called a HER2 mutation. The 152 participants had already tried at least one prior treatment that included platinum chemotherapy. The main goal was to see how safe the drug was and how well it worked to shrink or control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth Orlando
Orlando, Florida, 32803, United States
-
Aichi Cancer Center Hospital
Chikusa, 464-8681, Japan
-
Asan Medical Center
Seoul, 3080, South Korea
-
Assistance Publique Hopitaux de Marseille AP-HM, Hopital NORD
Marseille, 13015, France
-
Azienda Ospedaliero-Universitaria San Luigi Gonzaga
Orbassano, 10043, Italy
-
CHU Nantes
Saint-Herblain, 44800, France
-
CHU toulouse - hôpital Larrey
Toulouse, 31059, France
-
Centre Leon Berard
Lyon, 69008, France
-
Chang Gung Memorial Hospital CGMH - LinKou Branch
Taoyuan District, 333, Taiwan
-
Chung Shan Medical University Hospital
Taichung, 40705, Taiwan
-
Chungbuk National University Hospital
Jungbuk, 28644, South Korea
-
Clinica Univ. de Navarra - P
Pamplona, 31008, Spain
-
Clinica Universidad de Navarra
Madrid, 28027, Spain
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Erasmus MC
Rotterdam, 3015 GD, Netherlands
-
Gustav Roussy
Villejuif, 94800, France
-
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, 33612, United States
-
Henry Ford Cancer Institute/Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
Hopital Pontchaillou
Rennes, 35000, France
-
Hospital 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitari i Politècnic La Fe
Valencia, 46026, Spain
-
Hospital Universitario Fundacion Jimenez Diaz
Madrid, 28040, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, 08023, Spain
-
Humanitas Cancer Center Istituto Clinico Humanitas
Rozzano, 20089, Italy
-
IRCCS Istituto Europeo di Oncologia
Milan, 20141, Italy
-
Istituto Nazionale Tumori Fondazione G. Pascale di Napoli Strutturadi Oncologia
Napoli, 80131, Italy
-
Kindai University Hospital
Ōsaka-sayama, 589-8511, Japan
-
Massachusetts General Hospital (MGH) - Hematology/Oncology
Boston, Massachusetts, 02114, United States
-
National Cancer Center Hospital East
Kashiwa, 277-0882, Japan
-
National Cancer Central Hospital
Chūōku, 104-0045, Japan
-
National Cheng Kung University Hospital NCKUH
Tainan, 704, Taiwan
-
National Hospital Organization Kyushu Cancer Center
Fukuoka, 11111, Japan
-
National Taiwan University Hospital
Taipei, 10002, Taiwan
-
Netherlands Cancer Institute
Amsterdam, 1066CX, Netherlands
-
Norton Cancer Institute
Louisville, Kentucky, 40241, United States
-
Okayama University Hospital
Okayama, 700-8558, Japan
-
Ospedale San Luca
Lucca, 55100, Italy
-
Princess Alexandra Hospital
Woolloongabba, 4102, Australia
-
SC Oncologia, AOU Policlinico Modena
Modena, 41124, Italy
-
Samsung Medical Center
Seoul, 6351, South Korea
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Seoul National University Bundang Hospital
Seongnam, 463-707, South Korea
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
St John of God Subiaco Hospital
Subiaco, 6008, Australia
-
Taichung Veterans General Hospital
Taichung, 40705, Taiwan
-
University Health Network
Toronto, M5G0A3, Canada
-
University of Colorado Denver - Anschutz Medical Campus
Aurora, Colorado, 80045, United States
-
University of Michigan
Detroit, Michigan, 48202, United States
-
Virgina Cancer Specialists
Fairfax, Virginia, 22031, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.